XBiotech Inc. — Director's Dealing 2018

Mar 26, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: XBiotech Inc. (XBIT)
CIK: 0001626878
Period of Report: 2018-03-21

Reporting Person: HAN QUEENA (VP Finance & HR)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-03-21	Common Stock	M	9599	$2.50	Acquired	9599	Direct
2018-03-21	Common Stock	S	9599	$4.4783	Disposed	0	Direct
2018-03-22	Common Stock	M	62200	$2.50	Acquired	62200	Direct
2018-03-22	Common Stock	S	62200	$4.7614	Disposed	0	Direct
2018-03-23	Common Stock	M	8201	$2.50	Acquired	8201	Direct
2018-03-23	Common Stock	S	8201	$4.75	Disposed	0	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-03-21	Stock options	$2.50	M	9599	Disposed	2018-04-23	Common Stocks (9599)	Direct
2018-03-22	Stock options	$2.50	M	62200	Disposed	2018-04-23	Common Stock (62200)	Direct
2018-03-23	Stock options	$2.50	M	8201	Disposed	2018-04-23	Common Stock (8201)	Direct

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.75 to $4.85, inclusive. The reporting person undertakes to provide to XBIT, any security holder of XBIT, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.75 to $4.77, inclusive. The reporting person undertakes to provide to XBIT, any security holder of XBIT, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.